Bupropion Hydrochloride Tablet, Film Coated
Product Images NDC 50268-142

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 50268-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of Bupropion Hydrochloride showing molecular groups and chlorine atom, representing the active ingredient in the drug.*

FDA Label Image

1 (142 15)

Packaging label for Bupropion Hydrochloride Tablets, USP 75 mg, film-coated tablets, oral use, supplied in a unit dose package of 50 tablets (5 x 10). The label includes a warning about drug interactions, dosage instructions, storage conditions, manufacturer AvPAK, and a barcode.*

FDA Label Image

1 (143 15)

Label for Bupropion Hydrochloride Tablets USP, 100 mg, film-coated oral tablets, manufactured by AvPAK. The label shows dosing instructions as three times daily after initial titration, with packaging containing 50 tablets (5 x 10 unit dose). It includes a warning about avoiding use with Zybano or other bupropion hydrochloride medications, storage instructions, and pharmacist dispensing directions. The label features barcodes and is marked Rx Only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.